Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aclaris Therapeutics, Inc. ACRS

Full chart Compare
Set alert

Price alert · ACRS

All alert types
3.61 USD -0.07 (-1.90%)

At closeNov 6, 2026, 4:53 AM EST

3.89 +0.28 +7.79%

Pre-market · Nov 6, 4:53 AM ET

3.45 Day range 3.72
2.10 52-week range 6.60
YTD
+19.93%
1 year
+59.73%

Financial health

Altman Z-Score

-0.42 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -5.7×
FY 2016: -12.1×FY 2017: -10.1×FY 2018: -1.8×FY 2019: -0.5×FY 2020: -5.4×FY 2021: -9.1×FY 2022: -11.8×FY 2023: -0.8×FY 2024: -1.5×FY 2025: -5.7×
FY 2016 5y median -5.7× FY 2025
P/S 47.2×
FY 2016: 0.0×FY 2017: 412×FY 2018: 24.1×FY 2019: 18.5×FY 2020: 42.5×FY 2021: 122×FY 2022: 34.5×FY 2023: 2.3×FY 2024: 10.2×FY 2025: 47.2×
FY 2016 5y median 34.5× FY 2025
P/B 3.6×
FY 2016: 3.4×FY 2017: 3.1×FY 2018: 1.1×FY 2019: 1.1×FY 2020: 7.3×FY 2021: 4.2×FY 2022: 5.2×FY 2023: 0.5×FY 2024: 1.2×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
P/FCF -7.8×
FY 2016: -16.7×FY 2017: -12.4×FY 2018: -2.4×FY 2019: -0.8×FY 2020: -7.0×FY 2021: -15.7×FY 2022: -15.1×FY 2023: -0.9×FY 2024: -9.5×FY 2025: -7.8×
FY 2016 5y median -9.5× FY 2025
EV/EBITDA -5.5×
FY 2016: -11.3×FY 2017: -9.1×FY 2018: -2.6×FY 2019: -0.5×FY 2020: -5.6×FY 2021: -12.4×FY 2022: -11.6×FY 2023: -0.3×FY 2024: -3.2×FY 2025: -5.5×
FY 2016 5y median -5.5× FY 2025
EV/Sales 44.9×
FY 2016: 0.0×FY 2017: 288×FY 2018: 21.5×FY 2019: 10.5×FY 2020: 40.8×FY 2021: 118×FY 2022: 33.0×FY 2023: 1.1×FY 2024: 8.9×FY 2025: 44.9×
FY 2016 5y median 33.0× FY 2025
FCF Yield -12.8%
FY 2016: -6.0%FY 2017: -8.1%FY 2018: -42.0%FY 2019: -125.6%FY 2020: -14.2%FY 2021: -6.4%FY 2022: -6.6%FY 2023: -108.6%FY 2024: -10.5%FY 2025: -12.8%
FY 2016 5y median -10.5% FY 2025

Profitability

Gross Margin 73.3%
FY 2016: 0.0%FY 2017: 28.3%FY 2018: 32.1%FY 2019: 4.1%FY 2020: 20.8%FY 2021: 30.3%FY 2022: 59.8%FY 2023: 42.1%FY 2024: 85.1%FY 2025: 73.3%
FY 2016 5y median 59.8% FY 2025
Operating Margin -975.9%
FY 2016: 0.0%FY 2017: -4303.2%FY 2018: -1341.9%FY 2019: -2627.3%FY 2020: -785.4%FY 2021: -1327.1%FY 2022: -302.0%FY 2023: -311.6%FY 2024: -758.2%FY 2025: -975.9%
FY 2016 5y median -758.2% FY 2025
Net Margin -829.6%
FY 2016: 0.0%FY 2017: -4071.5%FY 2018: -1315.4%FY 2019: -3817.2%FY 2020: -787.0%FY 2021: -1344.0%FY 2022: -292.1%FY 2023: -283.1%FY 2024: -705.5%FY 2025: -829.6%
FY 2016 5y median -705.5% FY 2025
ROE -63.0%
FY 2016: -28.4%FY 2017: -30.4%FY 2018: -61.7%FY 2019: -230.8%FY 2020: -135.5%FY 2021: -46.0%FY 2022: -44.0%FY 2023: -56.3%FY 2024: -84.9%FY 2025: -63.0%
FY 2016 5y median -56.3% FY 2025
ROIC -57.7%
FY 2016: -28.5%FY 2017: -30.6%FY 2018: -54.5%FY 2019: -145.2%FY 2020: -89.8%FY 2021: -39.2%FY 2022: -38.5%FY 2023: -58.1%FY 2024: -75.2%FY 2025: -57.7%
FY 2016 5y median -57.7% FY 2025
ROA -40.5%
FY 2016: -27.3%FY 2017: -28.1%FY 2018: -48.2%FY 2019: -164.1%FY 2020: -72.1%FY 2021: -36.2%FY 2022: -34.1%FY 2023: -44.8%FY 2024: -59.9%FY 2025: -40.5%
FY 2016 5y median -40.5% FY 2025

Growth (YoY)

Revenue -58.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 499.6%FY 2019: -58.1%FY 2020: 53.3%FY 2021: 4.3%FY 2022: 340.1%FY 2023: 5.0%FY 2024: -40.1%FY 2025: -58.2%
FY 2016 FY 2025
Operating Income 46.2%
FY 2016: -135.0%FY 2017: -49.1%FY 2018: -87.0%FY 2019: 18.0%FY 2020: 54.2%FY 2021: -76.2%FY 2022: -0.1%FY 2023: -8.4%FY 2024: -45.8%FY 2025: 46.2%
FY 2016 FY 2025
EPS (diluted) 69.0%
FY 2016: -104.5%FY 2017: -8.4%FY 2018: -65.2%FY 2019: 14.1%FY 2020: 65.3%FY 2021: -33.3%FY 2022: 16.9%FY 2023: 4.5%FY 2024: -34.6%FY 2025: 69.0%
FY 2016 FY 2025
Free Cash Flow -133.3%
FY 2016: -66.9%FY 2017: -60.5%FY 2018: -82.8%FY 2019: 4.0%FY 2020: 60.1%FY 2021: -34.2%FY 2022: -30.0%FY 2023: -16.8%FY 2024: 74.6%FY 2025: -133.3%
FY 2016 FY 2025

Financial Health

Current Ratio 5.3×
FY 2016: 28.0×FY 2017: 16.4×FY 2018: 6.6×FY 2019: 3.7×FY 2020: 3.9×FY 2021: 8.9×FY 2022: 10.6×FY 2023: 4.2×FY 2024: 4.0×FY 2025: 5.3×
FY 2016 5y median 5.3× FY 2025
Quick Ratio 5.3×
FY 2016: 28.0×FY 2017: 16.9×FY 2018: 6.5×FY 2019: 3.7×FY 2020: 3.9×FY 2021: 8.9×FY 2022: 10.6×FY 2023: 4.2×FY 2024: 4.0×FY 2025: 5.3×
FY 2016 5y median 5.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.6×FY 2017: 3.9×FY 2018: 0.3×FY 2019: 0.4×FY 2020: 0.2×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.5×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31